These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

206 related items for PubMed ID: 8555032

  • 21. Methotrexate hepatotoxicity in psoriatics: report of 104 patients from Nova Scotia, with analysis of risks from obesity, diabetes and alcohol consumption during long term follow-up.
    Malatjalian DA, Ross JB, Williams CN, Colwell SJ, Eastwood BJ.
    Can J Gastroenterol; 1996 Oct; 10(6):369-75. PubMed ID: 9193771
    [Abstract] [Full Text] [Related]

  • 22. Methotrexate hepatotoxicity in psoriatic patients submitted to long-term therapy.
    Themido R, Loureiro M, Pecegueiro M, Brandão M, Campos MC.
    Acta Derm Venereol; 1992 Sep; 72(5):361-4. PubMed ID: 1361285
    [Abstract] [Full Text] [Related]

  • 23. The role of liver biopsies in psoriatic patients receiving long-term methotrexate treatment. Improvement in liver abnormalities after cessation of treatment.
    Newman M, Auerbach R, Feiner H, Holzman RS, Shupack J, Migdal P, Culubret M, Camuto P, Tobias H.
    Arch Dermatol; 1989 Sep; 125(9):1218-24. PubMed ID: 2774597
    [Abstract] [Full Text] [Related]

  • 24. Methotrexate revisited: effects of long-term treatment in psoriasis.
    Van Dooren-Greebe RJ, Kuijpers AL, Mulder J, De Boo T, Van de Kerkhof PC.
    Br J Dermatol; 1994 Feb; 130(2):204-10. PubMed ID: 8123573
    [Abstract] [Full Text] [Related]

  • 25. Biochemical and biophysical assessment of MTX-induced liver fibrosis in psoriasis patients: Fibrotest predicts the presence and Fibroscan predicts the absence of significant liver fibrosis.
    Berends MA, Snoek J, de Jong EM, Van Krieken JH, de Knegt RJ, van Oijen MG, van de Kerkhof PC, Drenth JP.
    Liver Int; 2007 Jun; 27(5):639-45. PubMed ID: 17498249
    [Abstract] [Full Text] [Related]

  • 26. Weekly vs. daily administration of oral methotrexate (MTX) for generalized plaque psoriasis: a randomized controlled clinical trial.
    Radmanesh M, Rafiei B, Moosavi ZB, Sina N.
    Int J Dermatol; 2011 Oct; 50(10):1291-3. PubMed ID: 21950300
    [Abstract] [Full Text] [Related]

  • 27. Abnormalities of serum type III procollagen aminoterminal peptide in methotrexate-treated psoriatic patients with normal liver histology do not correlate with hepatic ultrastructural changes.
    Oogarah PK, Rowland PL, Mitchell DM, Smith A, Chalmers RJ, Rowan B, Haboubi NY.
    Br J Dermatol; 1995 Oct; 133(4):512-8. PubMed ID: 7577576
    [Abstract] [Full Text] [Related]

  • 28. A retrospective review of methotrexate-induced hepatotoxicity among patients with psoriasis in a tertiary dermatology center in Malaysia.
    Ng LC, Lee YY, Lee CK, Wong SM.
    Int J Dermatol; 2013 Jan; 52(1):102-5. PubMed ID: 23278617
    [Abstract] [Full Text] [Related]

  • 29. Liver biopsies from psoriatics treated with methotrexate.
    Ho MS, Cheah E, Tham SN, Teh LB, Ng HS, Thirumoorthy S.
    Ann Acad Med Singap; 1986 Apr; 15(2):210-4. PubMed ID: 3752896
    [Abstract] [Full Text] [Related]

  • 30. A prospective study of the effects of weekly oral methotrexate on liver biopsy.
    Warin AP, Landells JW, Levene GM, Baker H.
    Br J Dermatol; 1975 Sep; 93(3):321-7. PubMed ID: 1103936
    [Abstract] [Full Text] [Related]

  • 31. [Methotrexate in psoriasis: are routine biopsies necessary?].
    Guillaume JC.
    Ann Dermatol Venereol; 2006 Sep; 133(6-7):513-7. PubMed ID: 16885837
    [No Abstract] [Full Text] [Related]

  • 32. Methotrexate in psoriasis: 26 years' experience with low-dose long-term treatment.
    Haustein UF, Rytter M.
    J Eur Acad Dermatol Venereol; 2000 Sep; 14(5):382-8. PubMed ID: 11305380
    [Abstract] [Full Text] [Related]

  • 33. A pilot study of pharmacokinetically guided dosing of oral methotrexate in the initial phase of psoriasis treatment.
    Hroch M, Chladek J, Simkova M, Vaneckova J, Grim J, Martinkova J.
    J Eur Acad Dermatol Venereol; 2008 Jan; 22(1):19-24. PubMed ID: 18031504
    [Abstract] [Full Text] [Related]

  • 34. A liver fibrosis cocktail? Psoriasis, methotrexate and genetic hemochromatosis.
    Mathew J, Leong MY, Morley N, Burt AD.
    BMC Dermatol; 2005 Nov 29; 5():12. PubMed ID: 16316460
    [Abstract] [Full Text] [Related]

  • 35. Have methotrexate-induced liver fibrosis and cirrhosis become rare? A matter for reappraisal of routine liver biopsies.
    Zachariae H.
    Dermatology; 2005 Nov 29; 211(4):307-8. PubMed ID: 16286736
    [No Abstract] [Full Text] [Related]

  • 36. Liver fibrosis in patients with psoriasis and psoriatic arthritis on long-term, high cumulative dose methotrexate therapy.
    Lindsay K, Fraser AD, Layton A, Goodfield M, Gruss H, Gough A.
    Rheumatology (Oxford); 2009 May 29; 48(5):569-72. PubMed ID: 19273538
    [Abstract] [Full Text] [Related]

  • 37. The value of a baseline liver biopsy prior to methotrexate treatment.
    Dolan OM, Burrows D, Irvine A, Walsh M.
    Br J Dermatol; 1994 Dec 29; 131(6):891-4. PubMed ID: 7857846
    [Abstract] [Full Text] [Related]

  • 38. The effect of folic acid supplementation on the pharmacokinetics and pharmacodynamics of oral methotrexate during the remission-induction period of treatment for moderate-to-severe plaque psoriasis.
    Chládek J, Simková M, Vanecková J, Hroch M, Chládkova J, Martínková J, Vávrová J, Beránek M.
    Eur J Clin Pharmacol; 2008 Apr 29; 64(4):347-55. PubMed ID: 18163165
    [Abstract] [Full Text] [Related]

  • 39. Efficacy and safety of cyclosporine versus methotrexate in severe psoriasis: a study from north India.
    Sandhu K, Kaur I, Kumar B, Saraswat A.
    J Dermatol; 2003 Jun 29; 30(6):458-63. PubMed ID: 12810993
    [Abstract] [Full Text] [Related]

  • 40. Methotrexate in childhood psoriasis.
    Kumar B, Dhar S, Handa S, Kaur I.
    Pediatr Dermatol; 1994 Sep 29; 11(3):271-3. PubMed ID: 7971565
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.